Baltimore-based Personal Genome Diagnostics (PGDx), a pioneer in conducting patient-specific analyses aimed at identifying genomic alterations in tumors, has recruited veteran industry executive Antony Newton as it prepares for accelerated growth.

Newton, most recently vice president in the oncology division of Genzyme, was hired as Chief Commercial Officer. He had a 19-year career at Genzyme, at which he held a number of roles in marketing, commercial development and drug development.